Latest Breaking News On - Sylvia wheeler - Page 1 : comparemela.com

Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of Oncogenic MYB Synthesis, at the American Society of Clinical Oncology Annual Meeting (ASCO 2024)

Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of Oncogenic MYB Synthesis, at the American Society of Clinical Oncology Annual Meeting (ASCO 2024)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomAljanae reynoldsElizabeth wolffeSylvia wheelerTravis wager

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesStephen bradyAljanae reynoldsSylvia wheelerExchange commissionSociety for immunotherapy of cancerAmerican association for cancer researchCompany quarterly report on formSecurities exchangeTempest therapeutics incCancer prevention clinical trials networkNational cancer instituteJournal of cancer research communicationsDivision of cancer preventionCancer researchScientific meeting

RAPT Therapeutics Reports First Quarter 2024 Financial Results

RAPT Therapeutics Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Brian wongSylvia wheelerAljanae reynoldsExchange commissionTherapeutics incExchange commission onCompany annual report on formFirst quarter marchQuarter ended marchPrivate securities litigation reform actAnnual report

Tempest Reports Inducement Grant Under Nasdaq Listing Rule

BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing.

United statesAljanae reynoldsSylvia wheelerTempest therapeutics incCompensation committeeMedia contactsNasdaq tpstTempest therapeutics

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAljanae reynoldsSylvia wheelerTempest therapeutics incCompensation committeeMedia contacts